Anna Giulia Nappi
Overview
Explore the profile of Anna Giulia Nappi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dondi F, Miceli A, Rovera G, Feudo V, Battisti C, Rondini M, et al.
Bioengineering (Basel)
. 2024 Jul;
11(7).
PMID: 39061796
Introduction: The term theragnostic refers to the combination of a predictive imaging biomarker with a therapeutic agent. The promising application of prostate-specific membrane antigen (PSMA)-based radiopharmaceuticals in the imaging and...
2.
Nappi A, Santo G, Jonghi-Lavarini L, Miceli A, Lazzarato A, La Torre F, et al.
Hematol Rep
. 2024 Jan;
16(1):32-41.
PMID: 38247994
Fluorine-18 fluorodeoxyglucose ([F]FDG) is nowadays the leading positron emission tomography (PET) tracer for routine clinical work-ups in hematological malignancies; however, it is limited by false positive findings. Notably, false positives...
3.
Bianchi A, De Rimini M, Sciuto R, Annovazzi A, Di Traglia S, Bauckneht M, et al.
Cancer Biother Radiopharm
. 2023 Apr;
38(4):256-267.
PMID: 37098169
To assess the role of baseline F-fluorodeoxyglucose ([F]FDG)-positron emission tomography/computed tomography (PET/CT) in predicting response to immunotherapy after 6 months and overall survival (OS) in patients with lung cancer (LC)...
4.
Evangelista L, Bianchi A, Annovazzi A, Sciuto R, Di Traglia S, Bauckneht M, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765835
Aim: To examine the role of [18F]FDG PET/CT for assessing response to immunotherapy in patients with some solid tumors. Methods: Data recorded in a multicenter ( = 17), retrospective database...
5.
Nappi A, Altini C, DAlo C, Megna M, Niccoli Asabella A, Fiorella M, et al.
Recenti Prog Med
. 2022 Nov;
113(12):739-748.
PMID: 36420850
Purpose: The aim of this study was to assess the role of oropharingoesophageal scintigraphy (OPES) in the management of neurological patients, investigating the clinical value of semiquantitative analysis. Materials And...
6.
Ferrari C, Mammucci P, Lavelli V, Pisani A, Nappi A, Rubini D, et al.
Tomography
. 2022 Nov;
8(6):2709-2722.
PMID: 36412685
Nowadays, there is still no consensus on the most accurate PET radiopharmaceutical to early detect prostate cancer (PCa) relapse. A tailored radiotracer choice based on a specific patient's profile could...
7.
Sardaro A, Mammucci P, Pisani A, Rubini D, Nappi A, Bardoscia L, et al.
J Clin Med
. 2022 Aug;
11(16).
PMID: 36012988
Solitary fibrous tumor (SFT) of the central nervous system, previously named and classified with the term hemangiopericytoma (HPC), is rare and accounts for less than 1% of all intracranial tumors....
8.
Santo G, Laudicella R, Linguanti F, Nappi A, Abenavoli E, Vergura V, et al.
Diagnostics (Basel)
. 2022 Apr;
12(4).
PMID: 35453892
Aim: In this comprehensive review we present an update on the most relevant studies evaluating the utility of amino acid PET radiotracers for the evaluation of glioma recurrence as compared...
9.
[F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients
Nappi A, Ferrari C, Mammucci P, Rubini D, Lavelli V, Sardaro A, et al.
Cancers (Basel)
. 2022 Mar;
14(6).
PMID: 35326614
We investigated the [F]Fluciclovine PET/CT reliability in the early detection of recurrent prostate cancer (PCa) and its impact on therapeutic decision making. We retrospectively analyzed 58 [F]Fluciclovine PET/CT scans performed...
10.
Ferrari C, Nappi A, Santo G, Mammucci P, Rubini D, Tucci M, et al.
Cancers (Basel)
. 2021 Sep;
13(17).
PMID: 34503150
The widespread COVID-19 vaccination led to unexpected PET findings. Notably, axillary and interpectoral lymphadenopathies ipsilateral to the vaccine inoculation were observed. We aimed to assess the hypermetabolic lymphadenopathy (HLN) detection...